Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Don P. Wolf; Tomonari Hayama; Shoukhrat Mitalipov

doi:10.15252/embj.201797843

Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Don P. Wolf, Tomonari Hayama, Shoukhrat Mitalipov

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Abstract

The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

Original language	English (US)
Pages (from-to)	2659
Number of pages	1
Journal	EMBO Journal
Volume	36
Issue number	17
DOIs	https://doi.org/10.15252/embj.201797843
State	Published - Sep 1 2017

ASJC Scopus subject areas

Neuroscience(all)
Molecular Biology
Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)

Access to Document

10.15252/embj.201797843

Cite this

@article{ba88a91cef814ddc8c4d41a0688e5dfb,

title = "Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)",

abstract = "The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.",

author = "Wolf, {Don P.} and Tomonari Hayama and Shoukhrat Mitalipov",

note = "Publisher Copyright: {\textcopyright} 2017 The Authors.",

year = "2017",

month = sep,

day = "1",

doi = "10.15252/embj.201797843",

language = "English (US)",

volume = "36",

pages = "2659",

journal = "EMBO Journal",

issn = "0261-4189",

publisher = "Nature Publishing Group",

number = "17",

}

TY - JOUR

T1 - Corrigendum to

T2 - Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

AU - Wolf, Don P.

AU - Hayama, Tomonari

AU - Mitalipov, Shoukhrat

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

AB - The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

UR - http://www.scopus.com/inward/record.url?scp=85028521849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028521849&partnerID=8YFLogxK

U2 - 10.15252/embj.201797843

DO - 10.15252/embj.201797843

M3 - Comment/debate

C2 - 28864679

AN - SCOPUS:85028521849

SN - 0261-4189

VL - 36

SP - 2659

JO - EMBO Journal

JF - EMBO Journal

IS - 17

ER -

Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this